Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
Clinical trial NCT04282109 · COMPLETED
Trial details
- NCT number
- NCT04282109
- Sponsor
- Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2023-09-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.